National HealthCare Corp (NHC) President & COO reports stock gifts, holds options

Rhea-AI Filing Summary

National HealthCare Corp. insider Michael Ussery, the company’s President and COO, reported several gifts of common stock on 12/17/2025. The transactions, coded "G" and priced at $0, involved small blocks of shares, after which he directly beneficially owned 160,523 shares of National HealthCare common stock. He also holds stock options giving him the right to purchase 4,500 shares at $53.94 exercisable from 03/08/2024 and expiring on 03/08/2028, 9,000 shares at $94.10 exercisable from 03/05/2025 and expiring on 03/05/2029, and 15,000 shares at $90.62 exercisable from 02/24/2026 and expiring on 02/24/2030, all held directly.

Insider Trade Summary

Net Seller: 1,000 shares

Net Sell 9 txns

Insider Ussery Robert Michael

Role President & COO

Type	Security	Shares	Price	Value
Gift	Common Stock	40	$0.00	$0.00
Gift	Common Stock	40	$0.00	$0.00
Gift	Common Stock	95	$0.00	$0.00
Gift	Common Stock	740	$0.00	$0.00
Gift	Common Stock	40	$0.00	$0.00
Gift	Common Stock	45	$0.00	$0.00
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--

Holdings After Transaction: Common Stock — 160,523 shares (Direct); Option to Purchase Common Stock — 28,500 shares (Direct)

Footnotes (1)

1. F1. Total amount of shares beneficially owned following transactions reported for this Title of Securities on this form.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 12/18/2025 - 04:31 PM Learn about SEC filing dates

FAQ

What insider activity did NHC report for Michael Ussery on this Form 4?

The filing shows that Michael Ussery, President and COO of National HealthCare Corp. (NHC), reported multiple transactions in common stock on 12/17/2025, each coded as a "G" transaction, indicating gifts of shares at a reported price of $0.

How many NHC shares does Michael Ussery own after the reported transactions?

Following the reported gift transactions, Michael Ussery directly beneficially owned 160,523 shares of National HealthCare Corp. common stock, as stated in the Form 4.

What NHC stock options does Michael Ussery hold according to this filing?

The report lists three option grants: an option to purchase 4,500 shares of common stock at $53.94 exercisable from 03/08/2024 to 03/08/2028, an option to purchase 9,000 shares at $94.10 exercisable from 03/05/2025 to 03/05/2029, and an option to purchase 15,000 shares at $90.62 exercisable from 02/24/2026 to 02/24/2030, all held directly.

What does transaction code "G" mean for the NHC insider transactions?

In this Form 4 for NHC, each common stock transaction by Michael Ussery is marked with transaction code "G", which denotes a gift of securities, reported at a price of $0 per share.

What is Michael Ussery’s role and relationship to National HealthCare Corp.?

The filing identifies Michael Ussery as an officer of National HealthCare Corp. (NHC), serving as President & COO, and the Form 4 is filed by one reporting person.

Are the derivative securities in this NHC Form 4 held directly or indirectly?

All listed derivative securities—options to purchase 4,500, 9,000, and 15,000 shares of NHC common stock—are reported as beneficially owned with direct (D) ownership by Michael Ussery.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ussery Robert Michael

(Last) (First) (Middle)

100 VINE STREET

(Street)

MURFREESBORO TN 37130

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & COO

3. Date of Earliest Transaction (Month/Day/Year)
12/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/17/2025		G		40	D	$0	161,483	D
Common Stock	12/17/2025		G		40	D	$0	161,443	D
Common Stock	12/17/2025		G		95	D	$0	161,348	D
Common Stock	12/17/2025		G		740	D	$0	160,608	D
Common Stock	12/17/2025		G		40	D	$0	160,568	D
Common Stock	12/17/2025		G		45	D	$0	160,523(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$53.94							03/08/2024	03/08/2028	Common Stock	4,500		4,500	D
Option to Purchase Common Stock	$94.1							03/05/2025	03/05/2029	Common Stock	9,000		9,000	D
Option to Purchase Common Stock	$90.62							02/24/2026	02/24/2030	Common Stock	15,000		15,000	D

Explanation of Responses:

1. Total amount of shares beneficially owned following transactions reported for this Title of Securities on this form.

	/s/ Michael Ussery	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.